Meeting
2023 ASCO Annual Meeting
Do bone scans over-stage disease compared to PSMA PET? An international multicenter retrospective study with blinded independent readers.
Authors
Wolfgang P. Fendler
Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
Wolfgang P. Fendler , Thomas A. Hope , Fei Jiang , Daniel Thompson , Francesco Barbato , Roxanna Juarez , Miguel Hernandez Pampaloni , Martin S. Auerbach , Pawan Gupta , Matthias R. Benz , Jeremie Calais
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Genitourinary Cancer—Prostate, Testicular, and Penile
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Epidemiology/Outcomes
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 5011)
DOI
10.1200/JCO.2023.41.16_suppl.5011
Abstract #
5011
Poster Bd #
105
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Low- and high-volume disease in mHSPC, from CHAARTED to PSMA-PET: An international multicenter retrospective study.
First Author: Lena Unterrainer
Poster
2021 Genitourinary Cancers Symposium
18F-fluciclovine positron emission tomography (PET) in metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone acetate.
First Author: Pedro C. Barata
Poster
2018 Genitourinary Cancers Symposium
Patterns of progression in bone and soft tissue following treatment with Ra-223 in metastatic castrate resistant prostate cancer (mCRPC).
First Author: Megan Ann McNamara
Poster
2017 Genitourinary Cancers Symposium
Association of PET index quantifying skeletal uptake in NaF PET/CT images with overall survival in prostate cancer patients.
First Author: Sarah Lindgren Belal